Table 3. Clinical outcomes.
Metabolic syndrome | p | ||
---|---|---|---|
| |||
Yes (34) | No (40) | ||
CVE, n (%) | 0.24 | ||
MI | 2 (5.9) | 0 (0.0) | |
Angina | 2 (5.9) | 1 (2.5) | |
CHF | 1 (2.9) | 1 (2.5) | |
NODAT, n (%) | 8 (25.3) | 2 (5.0) | 0.04 |
Acute rejection, n (%) | 12 (35.3) | 8 (20.0) | 0.14 |
Graft loss, n (%) | 6 (17.6) | 2 (5.0) | 0.08 |
Patients with any event*, n (%) | 21 (61.8) | 11 (27.5) | 0.003 |
eGFR, ml/min (SD) | 53.9 (21.2) | 57.1 (18.7) | 0.52 |
Some patients had more than one event.